NONE

Company

GT Biopharma, Inc.

Filed

February 18, 2016

Accession Number

0001140361-16-053774

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →